{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T21:40:28Z","timestamp":1698097228635},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T00:00:00Z","timestamp":1172793600000},"content-version":"vor","delay-in-days":7000,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[1988,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The effect of retinoic acid (RA) alone and in combination with cytosine arabinoside (Ara\u2010C) on differentiation of fresh human myeloid leukaemic cells from patients with AML was studied. Cells from six patients: three with acute myelomonocytic leukaemia AMMoL and three with acute monoblastic leukaemia AMoL with a percentage of blasts &gt; 70, were treated in an <jats:italic>in vitro<\/jats:italic> primary suspension culture with retinoic acid (10<jats:sup>\u22127<\/jats:sup> M), cytosine arabinoside (100 ng\/ml) or both in combination. Non\u2010adherent mononuclear cells were seeded at a concentration of 5 \u00d7 10<jats:sup>5<\/jats:sup> cells\/ml in RPMI 1640 culture medium supplemented with 20 per cent fetal bovine serum and 10 per cent (PHA\u2010LCM) phytohaemagglutinin leucocyte conditioned medium and incubated for 6 days at 37\u00b0C in a humidified incubator containing 5 per cent CO<jats:sub>2<\/jats:sub> in air. Morphological and functional differentiation into terminal mature elements was induced in all leukaemia cells of the six patients following exposure to the combination of both agents. These results suggest the potential usefulness of the combination of a differentiating agent (retinoic acid) and an antileukaemic drug (cytosine arabinoside) in the treatment of acute myeloid leukaemias: AMMoL and AMoL. This combination warrants a clinical trial.<\/jats:p>","DOI":"10.1002\/hon.2900060107","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T20:52:15Z","timestamp":1171918335000},"page":"39-45","source":"Crossref","is-referenced-by-count":28,"title":["Retinoic acid alone and in combination with cytosine arabinoside induces differentiation of human myelomonocytic and monoblastic leukaemic cells"],"prefix":"10.1002","volume":"6","author":[{"given":"H. T.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. K. H.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,2]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood.V45.4.485.485","article-title":"Interacting populations affecting proliferation of leukaemic cells in culture","volume":"45","author":"Aye M. T.","year":"1975","journal-title":"Blood"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03563.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-620"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V57.6.1000.1000","article-title":"Terminal differentiation of human promyelocytic leukaemia cells in primary culture in response to retinoic acid","volume":"57","author":"Breitman T. R.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V62.1.85.85","article-title":"Does treatment with Ara\u2010C in low dosage cause differentiation of leukaemic cells?","volume":"62","author":"Castaigne S.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(86)90265-1"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910250208"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V62.6.1211.1211","article-title":"Retinoic acid treatment of acute promyelocytic leukaemia: in vitro and in vivo observations","volume":"62","author":"Flynn P. J.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(85)90136-5"},{"key":"e_1_2_1_11_1","unstructured":"Hassan H. T.(1987).Review: Differentiation induction therapy of acute myelogenous leukaemias.Haematologia in press."},{"key":"e_1_2_1_12_1","first-page":"88","volume-title":"Haematological Cytochemistry","author":"Hayhoe F. G. J.","year":"1980"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(83)90424-8"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb07297.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60189-X"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000206836"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1987.tb00001.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.V62.4.709.709","article-title":"Induction of differentiation of human acute myelogenous leukaemia cells: Therapeutic implications","volume":"62","author":"Koeffler H. P.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910330122"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb02910.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1979.252"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1182\/blood.V55.5.859.859","article-title":"Differentiation of human leukaemias in response to 12\u2010O\u2010tetradecanoyl phorbol\u201013\u2010acetate in vitro","volume":"55","author":"Pegoraro L.","year":"1980","journal-title":"Blood"},{"key":"e_1_2_1_23_1","first-page":"1981","article-title":"Cell differentiation and bypassing of genetic defects in the suppression of malignancy","volume":"47","author":"Sachs L.","year":"1987","journal-title":"Cancer Res."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1985.193"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.37.10.1187"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2900060107","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2900060107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T14:23:32Z","timestamp":1697984612000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2900060107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1988,1]]}},"alternative-id":["10.1002\/hon.2900060107"],"URL":"https:\/\/doi.org\/10.1002\/hon.2900060107","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,1]]}}}